In plants, Cryptochromes are photoreceptors that negatively regulate CRL4 Cop1 (Cul4-RING ubiquitin ligase and its substrate receptor Cop1). In mammals, Cryptochromes are core components of the circadian clock and repressors of the glucocorticoid receptor (GR).
transcription-translation feedback loop (TTFL) by binding and inhibiting the Clock/Bmal1
complex within the forward limb of the clock. In addition, mammalian Cryptochromes regulate the activity of the glucocorticoid receptor (GR) and modulate cAMP signaling pathways important in gluconeogenesis [9, 10] .
Cop1 is also present in mammals where it functions as a DCAF protein allowing the 5 CRL4 Cop1 complex to recognize specific substrates [1] . In particular, mammalian Cop1 promotes the ubiquitylation and subsequent proteasomal-dependent degradation of downstream substrates (mostly transcription factors and metabolic enzymes), such as c-Jun, p53, Mta1, Stat3, Ets1, and Atgl [3, [11] [12] [13] [14] [15] . Thus, Cop1 constitutes a hub that rapidly modulates the stability of key cellular regulators in response to flux of nutrients and 10 hormones, as well as upon cellular stress.
Cop1 mediates the Cryptochromes-dependent rhythmic repression of the GR
Given the lack of physical interaction between mammalian Cryptochromes and Cop1 [8] , it is assumed that the Cryptochromes-Cop1 axis is not evolutionary conserved. However, functional studies to investigate the presence of this regulatory axis in mammals have not 15 been performed. As a first step towards this goal, we investigated the involvement of Cop1 in the well-established function of the mammalian Cryptochromes in repressing the GR transcriptional network [9] . Compared to wild-type mouse embryonic fibroblasts (MEFs), Cry1 -/-;Cry2 -/double knockout (DKO) MEFs display an elevated level of GR activity [9] . We expanded these findings by exogenously expressing either Cry1 or Cry2 using a 20 doxycycline-inducible system (TET-ON), in DKO MEFs. After activation of the GR pathway with dexamethasone (a synthetic glucocorticoid), we noticed that the expression of Sgk1 and Gilz, two canonical GR target genes, was reduced upon induction of either Cry1 or Cry2 ( Fig. S1A-B ).
To understand whether a genetic interaction between Cryptochromes and Cop1 is present in mammals, we measured dexamethasone-dependent activation of Sgk1 and Gilz upon depletion of Cop1. We found that Cop1 silencing inhibited GR-induced transcription of 5 Sgk1 and Gilz ( Fig. 1A and Fig. S1C ). Moreover, in cells depleted of Cop1, induction of Cry1 or Cry2 had no additional effect on the repression of Sgk1 and Gilz ( Fig. 1A and Fig. S1C ), suggesting that Cryptochromes and Cop1 operate in the same GR-repressing signaling pathway.
To analyze the function of the Cryptochrome-Cop1 axis in GR signaling in wild-type MEFs, 10 we stabilized endogenous Cryptochromes using the carbazole derivative KL001. KL001 competes with the CRL1 Fbxl3 , a Cul1-RING ubiquitin ligase complex, for its binding to Cryptochromes, thereby resulting in the inhibition of their ubiquitylation and degradation [16] [17] [18] [19] . First, we noticed that KL001 repressed the dexamethasone-mediated induction of Sgk1 and Gilz, in agreement with the accumulation of Cry2 in KL001-treated cells (Fig. 15 S1D). Moreover, in cells depleted of Cop1, KL001 treatment had no additive effect on the expression of Sgk1 and Gilz (Fig. 1B) . These data are in agreement with the results obtained with the induction of exogenous Cryptochromes in DKO MEFs and, together, they suggest that, in the absence of Cop1, Cryptochromes are impaired in their ability to inhibit GR. Moreover, these results indicate that KL001 acts through a novel pathway involving 20 Cop1 to inhibit GR activity.
Next, we performed differential expression analysis using RNA-sequencing to determine the impact of the genetic interactions between Cryptochromes, Cop1, and GR on a genomic scale. Dexamethasone-mediated activation of the GR was analyzed in wild-type MEFs treated with KL001 (to stabilize the Cryptochromes) in the presence or in the absence of Cop1 knockdown. We found that out of 3,540 genes significantly differentially expressed 5 by dexamethasone, 792 lost significant expression after KL001 treatment [see nextgeneration sequencing data deposited in Gene Expression Omnibus (GEO) database under the accession code GSE124388]. The scatter plots and the heatmap representations of these 792 genes shows that KL001 treatment blocked the effects of dexamethasone on both up-and down-regulated genes ( Fig. 1C and Fig. S1E ). Importantly, in cells depleted of 10 Cop1, KL001 treatment had no significant effect on these 792 GR-regulated genes ( Fig. 1C and Fig. S1E ). Altogether, these results indicate that Cop1 is a regulator of GR signaling and a downstream effector of the Cryptochromes-mediated repression of the GR transcriptional activity.
We also noticed that 396 GR-regulated genes were significantly differentially expressed 15 when dexamethasone was provided either together with KL001 or in Cop1 knockdown cells ( Fig. 1D , left panel). Motif enrichment analysis for these 396 genes showed that the first 7 most highly overrepresented motifs within the promoter regions of these genes contained the core sequence TGA C /GTCA which is the recognition site for AP-1 Cryptochromes mediate the rhythmic repression of GR in mouse liver, displaying its maximal and minimal response to dexamethasone at ZT2 and ZT10, respectively [9] . We confirmed and expanded these findings by showing that the expression of the GR target 5 genes Sgk1, Gilz, and Pck1 is inhibited in mouse liver specifically at ZT10, but not at ZT2 ( Fig. 1E) . To test whether time-of-day dependent GR target gene activation is dependent on Cop1, we depleted Cop1 in vivo using an adenoviral-mediated shRNA injected retroorbitally in mice. Confirming our data in cell systems, in vivo depletion of Cop1 was found to inhibit the dexamethasone-mediated activation of GR ( Fig. 1E ). Cop1 depletion inhibited 10 specifically the GR activation at ZT2 ( Fig. 1E ), when the GR is not repressed by the Cryptochromes [9] . Instead, Cop1 depletion at ZT10 did not additionally inhibit the activation of the GR, at a time when GR transcriptional activity is already repressed by the Cryptochromes. Again, these data confirm our results in MEFs where the Cryptochromesand Cop1-mediated transcriptional repression of GR are not additive ( Fig 
Cry2 controls the level and stability of Cop1's substrates
The above results revealed the existence of a genetic interaction among Cryptochromes and Cop1 that encouraged us to investigate the underlying mechanism. We noticed that the protein levels of c-Jun and JunB, two canonical Cop1 substrates, were lower in Cry1/2 DKO 20 MEFs than those present in MEFs isolated from wild-type littermate mice ( Fig. 2A) .
Similarly, Cop1, which is known to induce its own degradation [24], displayed lower levels in DKO MEFs compared to wild-type MEFs. Notably, doxycycline-mediated expression of [3] ]. We found that KL001 increased both the levels and stability of exogenous wild-type c-Jun ( Fig. 2F-G) . Instead, the c-Jun Cop1insensitive stable mutant was not further stabilized by KL001 treatment (Fig. 2H ). As The association between Cop1 and Cul4 is essential to form an active CRL4 Cop1 ubiquitin ligase complex and to mediate the ubiquitylation of downstream substrates [3] . Other subunits of the CRL4 Cop1 complex include Ddb1, which is also present in all CRL4 5 complexes, and Dda1, which is present in most but not all CRL4 complexes [4] . Moreover, CRL4 Cop1 is the only mammalian CRL4 complex known to contain an additional subunit, namely Det1, which plays an essential role as an assembly factor to link Cop1 to Ddb1 [3] .
Using a panel of eight DCAF proteins, we confirmed that Det1 specifically binds Cop1 ( Fig.   S3A ). We also confirmed that Cop1 associates more strongly with Cul4A than with its 10 paralog Cul4B, as previously observed [27] . Importantly, when we expressed increasing amounts of Det1 in HEK-293T cells, we observed that Cop1 co-immunoprecipitated increasing amounts of Cul4A, Dda1, and Ddb1 ( Fig. S3B ), suggesting that Det1 is a ratelimiting factor for Cop1 to associate with the rest of the CRL4 complex.
While in mammals Det1 is essential for Cop1 binding to Ddb1 and to form an active 15 CRL4 Cop1 complex, plant Det1 is not present in the CRL4 Cop1 complex formation and it assembles instead in a distinct ligase complex, namely CRL4 Det1 [1, 3, 5] . Moreover, plant Cryptochromes physically interact and inhibit Cop1, whereas in mammals this physical interaction is lost [8] . Because of these differences, we tested the hypothesis that mammalian Cryptochromes, instead of binding Cop1, could bind Det1.
20
Immunoprecipitation of HA-tagged Det1 expressed in HEK-293T cells revealed an interaction between Det1 and wild-type Cry2, which was tagged at the C-terminus with a FLAG epitope ( Fig. 3A ). We additionally noticed that adding a FLAG tag to the N-terminus of the two Cryptochrome proteins impaired their binding to Det1 (data not shown), suggesting that the N-terminal portion of the Cryptochrome is important for the binding to Det1. Therefore, we generated C-terminal deletion mutants of Cry2, all C-terminally tagged with a FLAG epitope (see schematics in Fig. 3B ) and tested them for their binding to Det1.
5
Immunopurification of HA-tagged Det1 co-expressed with either wild-type Cry2 or Cry2 truncation mutants revealed that the first N-terminal 130 amino acids of human Cry2 were sufficient for binding to Det1 ( Fig. 3A-B ). This is also divergent from the mechanism in planta where Cryptochromes bind and inhibit Cop1 through their C-terminal domain [26, 28] . Instead, the C-terminus of the mammalian Cryptochromes is critical for the interaction 10 with components of the circadian clock, such as the Period proteins and Fbxl3 [29-31].
Hence, it was not surprising that the Cry2-N130 truncation mutant, although able to interact with endogenous Det1, Dda1, and Ddb1, lost its ability to bind with the components of the circadian clock ( Fig. 3C ).
Notably, expression of the truncation mutant Cry2-N130 in U-2OS cells was sufficient to 
Cry1 and Cry2 inhibit the binding between Cop1 and Det1-Ddb1
Next, to gain insights into the role of Cryptochromes in the assembly of the CRL4 Cop1 complex, we immunopurified FLAG-tagged Cop1 expressed in HEK-293T cells either alone or in combination with Cry1 or Cry2. Mass-spectrometric analysis of the proteins present in the Cop1 complex showed that, when either Cry1 or Cry2 were co-expressed with Cop1, 5 there was a reduction in the number of peptides corresponding to endogenous Dda1, Ddb1, and Det1 ( Fig. S4A ). To confirm these data, we tested the interaction between Cop1 and puzzling the fact that they have no effect on the GR-dependent repression of the NF-B inflammatory gene network [9] . We propose that Cryptochromes repress GR via the Cop1- We studied the effect of the Cryptochromes-Cop1-GR axis on the GR transcriptional activity in cell systems and mouse liver. However, Cop1 has an ever-growing number of substrates, raising the possibility that the Cryptochromes-Cop1 axis controls a vast signaling network. 15 Thus, our study opens the door to future investigations on the Cryptochromes-dependent stabilization of Cop1 substrates and their specific roles in different organs and tissues. c-Jun cDNA was amplified by PCR using a cDNA library generated from HEK293T cells and sub-cloned into pBabe (Cell Biolabs). Human CRY2 mutants were generated by using the QuikChange Site-directed Mutagenesis kit (Stratagene). All cDNAs were sequenced.
Gene Silencing by siRNA
ON-TARGETplus SMARTpool siRNA oligos targeting either COP1 or TRIP6 were transfected using RNAi Max 20 (Dharmacon). ON-TARGETplus non-targeting siRNA (Dharmacon, catalog no. D-001810-01) served as a negative control.
Retro-and Lentivirus-Mediated Gene Transfer
HEK-293T cells were transiently co-transfected with retroviral (pBabe) vectors containing vesicular stomatitis virus G protein (VSV-G) and the gene of interest along with pCMV-Gag-Pol using polyethylenimine. 25
Alternatively, lentivirus (pTRIPZ) vectors containing vesicular stomatitis virus G protein (VSV-G) and the gene of interest along with pCMV Delta R8.2 were co-transfected using polyethylenimine. Retrovirus-or lentiviruscontaining medium, 48 hr after transfection, was collected and supplemented with 8 mg/ml Polybrene (Sigma). Cells of interest were then infected by replacing the cell culture medium with the viral supernatant for 6 hours. Selection of stable clones was carried out with puromycin. 30
Immunoprecipitation and immunoblotting HEK-293T cells were transiently transfected using polyethylenimine (PEI). U-2OS cells were transiently transfected using siLentFect (Bio-rad). Cell lysis was carried out with lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 10% glycerol, 1 mM EDTA, and 0.5% NP-40) supplemented with protease and phosphatase inhibitors.
35
Immunoprecipitations were carried out after 3 hours treatment with MG132 and with either an anti-FLAG antibody conjugated to agarose resin or an anti-HA antibody conjugated to agarose resin. For immunoprecipitation of endogenous proteins, wild-type iMEFs were collected and lysed with lysis buffer. Cop1 was immunoprecipitated with the listed antibody mixed with Protein A sepharose beads (Invitrogen). Elution of the immunoprecipitate was carried out with NuPAGE® LDS sample buffer (Thermo Fisher Scientific) 40
supplemented with β-mercaptoethanol (Sigma-Aldrich) and incubation at 95°C for 3 minutes. 
qRT-PCR
Total RNA was generated using RNeasy mini kits (Qiagen). cDNA was generated using Random Hexamers EcoDry kits (Takara Clontech). qPCR was performed using Absolute SYBR green (Thermo Fisher Scientific) on a Roche Lightcycler 480. Analysis of the qPCR experiments was conducted via absolute relative quantification with in-experiment standard curves for each primer set to control for primer efficiency. The oligos used for 15
qRT-PCR analysis are listed: 
Mass spectrometry
HEK-293T cells were transfected with constructs encoding either FLAG-tagged human COP1, co-transfected with GFP control vector, or human wild-type CRY1, or human wild-type CRY2. Forty-eight hours after 5 transfection, cells were collected and lysed in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, plus protease and phosphatase inhibitors). Proteins were immunopurified with anti-FLAG M2 agarose beads (Sigma) and, after extensive washing, eluted by competition with 3x-FLAG peptide (Sigma). The eluate was then precipitated with TCA. Next, mass-spectrometric analysis of the immunoprecipitates was carried out according to (32). 10
RNA Extraction and Next-Generation Sequencing Analysis
Libraries for RNA-seq were prepared according to manufacturer's instructions (Illumina). Briefly, total RNA was extracted from cultured cells using the RNeasy Plus Mini Kit (QIAGEN). Poly(A) RNA was isolated using Dynabeads Oligo(dT)25 (Invitrogen) and used as input for library construction utilizing the dUTP method. 15
Barcodes were used for sample multiplexing. RNA libraries were sequenced on an Illumina HiSeq. RNAseq differential expression analysis was performed for three lanes of a single-read 50 Illumina HiSeq 2500 run. Persample FASTQ files were generated using the bcl2fastq Conversion software (v.1.8.4) to convert per-cycle BCL base call files outputted by the sequencing instrument into the FASTQ format. The alignment program, STAR (v2.4.5a), was used for mapping reads of 24 mouse samples to the mouse reference genome mm10 and the 20 application FastQ Screen (v0.5.2) was utilized to check for contaminants. The software, featureCounts (Subread package v1.4.6-p3), was used to generate the matrix of read counts for annotated genomic features. For the differential gene statistical comparisons between groups of samples contrasted by non-targeting RNA interference and targeting Cop1 RNA interference conditions as well as KL001 and dexamethasone chemical treatments, the DESeq2 package (Bioconductor v3.3.0) in the R statistical programming environment was 25 utilized. The heatmap was generated using the function 'heatmap.2' within the package 'gplots' in the R statistical programming environment.
Transcription factor motif analysis Motifs enriched within promoters of dexamethasone-inducible genes whose expression was modified by 30 treatment with KL001 and COP1 siRNA were identified using the Homer script "findMotifs.pl" (PMID 20513432). Specifically, we supplied the gene IDs for either the 396 dexamethasone-regulated genes that were also differentially regulated by KL001 and siCOP1 treatment or the remaining 3144 dexamethasone-sensitive genes and searched for motifs among these two groups within -300 to +50 bp of the annotated transcription start site and allowing for at most two mismatched bases to known or de novo motif assignments. 35
Animals
All animal care and use procedures were in accordance with guidelines of the Institutional Animal Care and Use Committee. All experiments were performed using male C57BL/6J mice between 3-4 months of age, and mice were maintained on a 12:12 light dark (LD) cycle in the Northwestern University Center for Comparative 40
Medicine.
In vivo delivery of shRNA via adeno-associated virus (AAV)
AAV-technology was utilized to delivery shRNAs to liver tissues in vivo. AAVs were cloned, packaged into serotype 8, purified by Cesium Chloride centrifugation, concentrated to ~1x10 12 GC/mL, and buffer exchanged to PBS w/5% glycerol by Vector Biolabs (Malvern, PA).Pre-validated shRNAs targeting mRFWD2 (Cop1, NM_011931) or a scrambled control were expressed under the U6 promoter and GFP was co-expressed under the CMV promoter. Mice were anaesthetized using isoflurane inhalation and 1x10 11 GC (100 µL) of AAV 5 expressing either shCop1 or scrambled control RNAs were delivered by retroorbital injection. After 4 weeks, mice were injected with 100 l saline alone or 1 g water-soluble dexamethasone (Sigma) resuspended in saline one hour prior to being sacrificed at ZT2 and ZT10. Liver tissue was excised and snap frozen in liquid nitrogen. Total RNA was extracted from frozen liver tissue using Tri-Reagent (Molecular Research Center, Inc), and quantitative PCR was performed and analyzed using a CFX384 (Bio-Rad). PCR conditions were: 10 min at 10 95°C, then 35 cycles of 10 s at 95°C, 15 s at 60°C. Relative expression levels (normalized to β-actin) were determined using the comparative CT method. 
Data availability
The next-generation sequencing data that support the findings of this study in Figure 1 and in Supplementary  25 figure 1 have been deposited in the Gene Expression Omnibus (GEO) database under the accession code GSE124388. All other data supporting the findings of this study are available from the corresponding author on reasonable request. (C) HEK-293T cells were transfected with either a control GFP expressing vector or a Cry2 wildtype expressing vector. The next day cycloheximide was applied to the cells for the indicated time and cells were then collected, lysed and immunoblotted with antibodies to the indicated proteins. 
